ATS 2024

New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy

SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) --

When:          May 17–22, 2024
Where:         San Diego Convention Center (SDCC) | 111 Harbor Dr. San Diego, CA 92101
                       Marriott Marquis San Diego Marina | 333 West Harbor Dr. San Diego, CA 92101

Research:     26 ResMed-supported abstracts will be presented at ATS. Full list below. Highlights:

• Treatment of Sleep-Disordered Breathing with Adaptive Servo-Ventilation (READ-ASV)
  in Opioid Users – a European Registry
  • Sunday May 19, 2024, 9:15 a.m. - 11:15 a.m., SDCC 32A-B
  • Presented by Jean-Louis Pepin, MD, Grenoble Alpes University, France
• An Estimate of the Prevalence of Obstructive Sleep Apnea in the United States into 2050
  • Monday, May 20, 9:15 a.m. - 4:15 p.m., SDCC Area C Hall A-B2
  • Presented by Elroy Boers, PhD, ResMed Science Center
• All-Cause Mortality in Obstructive Sleep Apnea
  • Monday, May 20, 2:15 p.m. - 4:15 p.m., SDCC 32A-B
  • Presented by Atul Malhotra, MD, University of California, San Diego
• Impact of Positive Airway Pressure (PAP) Therapy on Hospitalization in Obstructive Sleep Apnea (OSA): Analysis of a German Healthcare Database
  • Monday, May 20, 2:15 p.m. - 4:15 p.m., SDCC 32A-B
  • Presented by Holger Woehrle, MD, Ulm Lung Centre, Germany
• Treatment of Sleep-Disordered Breathing with Adaptive Servo-Ventilation – Outcomes in Patients with Treatment-Emergent or Persistent Central Sleep Apnea
  • Tuesday, May 21, 2:15 p.m. - 4:15 p.m., Marriott Marquis Pacific Ballroom 15-17
  • Presented by Michael Arzt, MD, Universitätsklinikum Regensburg, Germany
    

Innovation Hub:     Healthcare of Today, Looking Towards Tomorrow: Digital Innovations and Patient Centricity

• Monday, May 20, 1:15 - 1:35 p.m., SDCC Innovation Hub 4
• Presented by Monica Mallampalli, Chief Executive Officer at Alliance of Sleep Apnea Partners, and Carlos Nunez, ResMed Chief Medical Officer

Booth #1442:            Featuring ResMed’s latest innovations in respiratory care:

• AirCurve 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea
• AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask

Complete list of ResMed sponsored studies to be presented at ATS 2024: